A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
Huvudupphovsmän: | Landau, D, Miles, E, Illsley, M, Laurence, V, Hughes, S, Ngai, Y, Hughes, L, Khan, I, Mayles, H, Mayles, P, Fenwick, J |
---|---|
Materialtyp: | Journal article |
Publicerad: |
2013
|
Liknande verk
Liknande verk
-
Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
av: Panettieri, V, et al.
Publicerad: (2010) -
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
av: Fenwick, J, et al.
Publicerad: (2009) -
Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
av: Warren, S, et al.
Publicerad: (2014) -
Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
av: Fenwick, J, et al.
Publicerad: (2008) -
UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
av: Hughes, S, et al.
Publicerad: (2007)